Literature DB >> 123712

Aerosol Sch 1000. An anticholinergic bronchodilator.

W W Storms, G A DoPico, C E Reed.   

Abstract

Atropine is known to be an effective bonrchodilator. We studied the effectiveness of aerosol Sch 1000, a derivative of atropine, in relieving bronchoconstriction in asthma. A single dose of drug was effective within 5 min, and the effect had a duration of 4 hours. No side effects were noted. The major effect of the drug appeared to be in large airways.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 123712     DOI: 10.1164/arrd.1975.111.4.419

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  14 in total

Review 1.  On the action of combination bronchodilators.

Authors:  C J Hanna; P Eyre
Journal:  Agents Actions       Date:  1979-10

2.  Dual effect of prostaglandin E2 on normal airways smooth muscle in vivo.

Authors:  E H Walters; B H Davies
Journal:  Thorax       Date:  1982-12       Impact factor: 9.139

3.  Relaxant effects of selected bronchodilators on equine pulmonary vein and tracheal smooth muscle.

Authors:  J Hanna; P Eyre
Journal:  Lung       Date:  1980       Impact factor: 2.584

4.  Ipratropium bromide: are patients treated with optimal therapy?

Authors:  A B Millar; A Bush; H al-Hillawi; J Goldman; D M Denison
Journal:  Postgrad Med J       Date:  1990-12       Impact factor: 2.401

5.  Bronchodilator effect of sublingual isosorbide dinitrate in asthma.

Authors:  M Okayama; H Sasaki; T Takishima
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

6.  Nebulized salbutamol vs salbutamol and ipratropium combination in asthma.

Authors:  Anita Sharma; Arvind Madaan
Journal:  Indian J Pediatr       Date:  2004-02       Impact factor: 1.967

Review 7.  Anticholinergic agents for chronic asthma in adults.

Authors:  M Westby; M Benson; P Gibson
Journal:  Cochrane Database Syst Rev       Date:  2004

8.  Bronchodilatation and the site of airway resistance in severe chronic bronchitis.

Authors:  N J Douglas; I Davidson; M F Sudlow; D C Flenley
Journal:  Thorax       Date:  1979-02       Impact factor: 9.139

9.  Response to aerosol salbutamol, SCH 1000, and placebo in cystic fibrosis.

Authors:  M Kattan; A Mansell; H Levison; M Corey; I R Krastins
Journal:  Thorax       Date:  1980-07       Impact factor: 9.139

Review 10.  Ipratropium bromide: a review of its pharmacological properties and therapeutic efficacy in asthma and chronic bronchitis.

Authors:  G E Pakes; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1980-10       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.